287 related articles for article (PubMed ID: 24586509)
1. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.
Bondar C; Araya RE; Guzman L; Rua EC; Chopita N; Chirdo FG
PLoS One; 2014; 9(2):e89068. PubMed ID: 24586509
[TBL] [Abstract][Full Text] [Related]
2. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.
Loiseau C; Requena M; Nayrac M; Mavigner M; Cazabat M; Iscache AL; Carrere N; Suc B; Alric L; Izopet J; Delobel P
J Infect Dis; 2019 Jul; 220(5):830-840. PubMed ID: 30880342
[TBL] [Abstract][Full Text] [Related]
3. The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease.
Haghbin M; Rostami-Nejad M; Forouzesh F; Sadeghi A; Rostami K; Aghamohammadi E; Asadzadeh-Aghdaei H; Masotti A; Zali MR
Medicine (Baltimore); 2019 Jun; 98(25):e15949. PubMed ID: 31232926
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
5. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
[TBL] [Abstract][Full Text] [Related]
6. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
7. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
8. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
9. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
[TBL] [Abstract][Full Text] [Related]
10. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis.
Singh UP; Singh R; Singh S; Karls RK; Quinn FD; Taub DD; Lillard JW
BMC Immunol; 2008 Jun; 9():25. PubMed ID: 18533024
[TBL] [Abstract][Full Text] [Related]
11. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition.
Singh UP; Singh S; Singh R; Cong Y; Taub DD; Lillard JW
J Interferon Cytokine Res; 2008 Jan; 28(1):31-43. PubMed ID: 18370870
[TBL] [Abstract][Full Text] [Related]
12. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
Schroepf S; Kappler R; Brand S; Prell C; Lohse P; Glas J; Hoster E; Helmbrecht J; Ballauff A; Berger M; von Schweinitz D; Koletzko S; Lacher M
Inflamm Bowel Dis; 2010 Nov; 16(11):1882-90. PubMed ID: 20848514
[TBL] [Abstract][Full Text] [Related]
13. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
14. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
Hueso L; Ortega R; Selles F; Wu-Xiong NY; Ortega J; Civera M; Ascaso JF; Sanz MJ; Real JT; Piqueras L
Int J Obes (Lond); 2018 Aug; 42(8):1406-1417. PubMed ID: 29795466
[TBL] [Abstract][Full Text] [Related]
18. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
Yoon KC; Park CS; You IC; Choi HJ; Lee KH; Im SK; Park HY; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):643-50. PubMed ID: 19850844
[TBL] [Abstract][Full Text] [Related]
19. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
